Safety and Reactogenicity of the Booster Dose of 2 Investigational Protein-Based Pneumococcal Vaccine Formulations in Toddlers: A Phase II Randomized Trial | Zendy

AI Assistant Blog Pricing

Safety and Reactogenicity of the Booster Dose of 2 Investigational Protein-Based Pneumococcal Vaccine Formulations in Toddlers: A Phase II Randomized Trial

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.